DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2017 Financial Results

VANCOUVER, British Columbia and MENLO PARK, Calif., May 18, 2017 /PRNewswire/ —¬†DelMar Pharmaceuticals, Inc. (DMPI) (“DelMar” and the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced its financial results for the quarter ending March 31, 2017, the third quarter of the Company’s 2017 fiscal year. DelMar’s executive management will host a business update conference call and live webcast for investors, analysts and other interested parties on Wednesday May 24th, 2017 at 4:30 p.m. Eastern Standard Time.